Skip to content
Accessibility help

Search NICE…

Skip to content

Guidance
Standards and indicators
Life sciences
British National Formulary (BNF)
British National Formulary for Children (BNFC)
Clinical Knowledge Summaries (CKS)
About

Search results

Skip to results

Area of interest

Area of interestAntimicrobial prescribing (43)COVID-19 (36)

Type

TypeGuidance (3882)Indicators (267)News (230)NICE advice (496)Quality standards (255)Research recommendations (1922)

Status

StatusAwaiting development (328)Discontinued (382)In consultation (6)In development (422)Published (2460)Topic selection (288)

Last updated

Last updatedLast 3 months (60)Last 6 months (142)Last year (584)Last 3 years (1774)

Guidance programme

Guidance programmeAntimicrobial prescribing guidelines (25)Cancer service guidelines (10)Clinical guidelines (380)COVID-19 NHSE/I specialty guides (2)COVID-19 rapid guidelines (27)Diagnostics guidance (93)Health technology evaluations (38)Highly specialised technologies guidance (47)Interventional procedures guidance (950)Medical technologies guidance (154)Medicines practice guidelines (5)NICE guidelines (562)Public health guidelines (88)Safe staffing guidelines (7)Social care guidelines (47)Technology appraisal guidance (2034)

Advice programme

Advice programmeCOVID-19 rapid summaries (8)Evidence summaries (172)Medtech innovation briefings (324)

Showing 6841 to 6855 of 7680 results

Sort by

Niraparib for previously treated hormone-relapsed metastatic prostate cancer with DNA-repair anomalies [ID3782]
Discontinued [GID-TA10635]
Result type
Technology appraisal guidance
Status
Discontinued
Atezolizumab in combination for advanced epithelial ovarian, fallopian tube or primary peritoneal cancer in people who have not received any prior systemic therapy [ID2700]
Discontinued [GID-TA10574]
Result type
Technology appraisal guidance
Status
Discontinued
Neratinib for treating HER2-positive breast cancer after 2 therapies [ID1381]
Discontinued [GID-TA10539]
Result type
Technology appraisal guidance
Status
Discontinued
Tisagenlecleucel for treating relapsed or refractory aggressive diffuse large B-cell lymphoma after 1 systemic therapy [ID3974]
Discontinued [GID-TA10859]
Result type
Technology appraisal guidance
Status
Discontinued
Skin abscess: antimicrobial prescribing
Discontinued [GID-NG10163]
Result type
Antimicrobial prescribing guideline
Status
Discontinued
Blepharitis: antimicrobial prescribing
Discontinued [GID-NG10168]
Result type
Antimicrobial prescribing guideline
Status
Discontinued
Interferon beta-1b, interferon beta-1a and glatiramer acetate for the treatment of single demyelinating event with clinically isolated syndrome [ID109]
Discontinued [GID-TAG415]
Result type
Technology appraisal guidance
Status
Discontinued
Vandetanib for treating metastatic, differentiated thyroid cancer refractory to or unsuitable for radioiodine therapy [ID907]
Discontinued [GID-TA11259]
Result type
Technology appraisal guidance
Status
Discontinued
Bavituximab for treating non-squamous non-small-cell lung cancer after platinum-based chemotherapy [ID975]
Discontinued [GID-TA11260]
Result type
Technology appraisal guidance
Status
Discontinued
Triptorelin for the adjuvant treatment of early breast cancer in premenopausal women [ID976]
Discontinued [GID-TA11261]
Result type
Technology appraisal guidance
Status
Discontinued
Ataluren for treating cystic fibrosis in people with a CFTR gene nonsense mutation [ID955]
Discontinued [GID-TA11262]
Result type
Technology appraisal guidance
Status
Discontinued
ADI-PEG 20 for previously treated hepatocellular carcinoma [ID1025]
Discontinued [GID-TA10259]
Result type
Technology appraisal guidance
Status
Discontinued
Nilotinib for the first line treatment of chronic myeloid leukaemia [ID79]
Discontinued [GID-TAG408]
Result type
Technology appraisal guidance
Status
Discontinued
Psoriatic arthritis (moderate to severe) - leflunomide [ID391]
Discontinued [GID-TAG385]
Result type
Technology appraisal guidance
Status
Discontinued
Histamine dihydrochloride with interleukin-2 for maintenance treatment of acute myeloid leukaemia [ID1627]
In development [GID-TA10575] Expected publication date: TBC
Result type
Technology appraisal guidance
Status
In development

Previous page
1
…
455
456
Current page 457
458
459
…
512
Page 457 of 512
Next page

Guidance
Standards and indicators
Life sciences
British National Formulary (BNF)
British National Formulary for Children (BNFC)
Clinical Knowledge Summaries (CKS)
Knowledge resources

About NICE
Into practice
Get involved with NICE
Jobs
News
Newsletters and alerts
Contact us
Leave feedback
Reusing our content
NICE UK Open Content Licence
Syndicate our content
Events

Facebook
X
YouTube
LinkedIn

Accessibility
Freedom of information
Glossary
Terms and conditions
Privacy notice
Cookies

© NICE 2024. All rights reserved. Subject to Notice of rights.